Literature DB >> 28855387

A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity.

Ana Catarina Alves1, Daniela Ribeiro1, Miguel Horta1, José L F C Lima1, Cláudia Nunes2, Salette Reis1.   

Abstract

Daunorubicin is extensively used in chemotherapy for diverse types of cancer. Over the years, evidence has suggested that the mechanisms by which daunorubicin causes cytotoxic effects are also associated with interactions at the membrane level. The aim of the present work was to study the interplay between daunorubicin and mimetic membrane models composed of different ratios of 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), sphingomyelin (SM) and cholesterol (Chol). Several biophysical parameters were assessed using liposomes as mimetic model membranes. Thereby, the ability of daunorubicin to partition into lipid bilayers, its apparent location within the membrane and its effect on membrane fluidity were investigated. The results showed that daunorubicin has higher affinity for lipid bilayers composed of DMPC, followed by DMPC : SM, DMPC : Chol and lastly by DMPC : SM : Chol. The addition of SM or Chol into DMPC membranes not only increases the complexity of the model membrane but also decreases its fluidity, which, in turn, reduces the amount of anticancer drug that can partition into these mimetic models. Fluorescence quenching studies suggest a broad distribution of the drug across the bilayer thickness, with a preferential location in the phospholipid tails. The gathered data support that daunorubicin permeates all types of membranes to different degrees, interacts with phospholipids through electrostatic and hydrophobic bonds and causes alterations in the biophysical properties of the bilayers, namely in membrane fluidity. In fact, a decrease in membrane fluidity can be observed in the acyl region of the phospholipids. Ultimately, such outcomes can be correlated with daunorubicin's biological action, where membrane structure and lipid composition have an important role. In fact, the results indicate that the intercalation of daunorubicin between the phospholipids can also take place in rigid domains, such as rafts that are known to be involved in different receptor processes, which are important for cellular function.
© 2017 The Author(s).

Entities:  

Keywords:  daunorubicin; drug–membrane interactions; fluidity; liposomes; location; partition

Mesh:

Substances:

Year:  2017        PMID: 28855387      PMCID: PMC5582131          DOI: 10.1098/rsif.2017.0408

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  49 in total

1.  Structure-activity relationship of P-glycoprotein substrates and modifiers.

Authors:  A Seelig; E Landwojtowicz
Journal:  Eur J Pharm Sci       Date:  2000-11       Impact factor: 4.384

2.  Lipid-drug interaction: biophysical effects of tolmetin on membrane mimetic systems of different dimensionality.

Authors:  Cláudia Nunes; Gerald Brezesinski; Daniela Lopes; José L F C Lima; Salette Reis; Marlene Lúcio
Journal:  J Phys Chem B       Date:  2011-10-11       Impact factor: 2.991

Review 3.  Drug-membrane interactions: significance for medicinal chemistry.

Authors:  M Lúcio; J L F C Lima; S Reis
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 4.  Biophysics in cancer: The relevance of drug-membrane interaction studies.

Authors:  Ana Catarina Alves; Daniela Ribeiro; Cláudia Nunes; Salette Reis
Journal:  Biochim Biophys Acta       Date:  2016-06-29

5.  Localization of adriamycin in model and natural membranes. Influence of lipid molecular packing.

Authors:  L Dupou-Cézanne; A M Sautereau; J F Tocanne
Journal:  Eur J Biochem       Date:  1989-05-15

Review 6.  Role of cholesterol and lipid organization in disease.

Authors:  Frederick R Maxfield; Ira Tabas
Journal:  Nature       Date:  2005-12-01       Impact factor: 49.962

7.  Interaction of Daunomycin with Dipalmitoylphosphatidylcholine Model Membranes. A 1H NMR Study

Authors: 
Journal:  J Magn Reson B       Date:  1996-09

8.  Modification of membrane heterogeneity by antipsychotic drugs: an X-ray diffraction comparative study.

Authors:  Cedric Tessier; Philippe Nuss; Galya Staneva; Claude Wolf
Journal:  J Colloid Interface Sci       Date:  2008-01-31       Impact factor: 8.128

9.  Shape of the fluidity gradient in the plasma membrane of living HeLa cells.

Authors:  J M Collins; R N Dominey; W M Grogan
Journal:  J Lipid Res       Date:  1990-02       Impact factor: 5.922

10.  Disruption of cellular signaling pathways by daunomycin through destabilization of nonlamellar membrane structures.

Authors:  P V Escribá; M Sastre; J A García-Sevilla
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

View more
  11 in total

1.  Variational autoencoders learn transferrable representations of metabolomics data.

Authors:  Daniel P Gomari; Annalise Schweickart; Leandro Cerchietti; Elisabeth Paietta; Hugo Fernandez; Hassen Al-Amin; Karsten Suhre; Jan Krumsiek
Journal:  Commun Biol       Date:  2022-06-30

Review 2.  Combined Second Harmonic Generation and Fluorescence Analyses of the Structures and Dynamics of Molecules on Lipids Using Dual-Probes: A Review.

Authors:  Yi Hou; Jianhui Li; Bifei Li; Qunhui Yuan; Wei Gan
Journal:  Molecules       Date:  2022-06-11       Impact factor: 4.927

3.  Cholesterol and Its Derivatives: Multifaceted Players in Breast Cancer Progression.

Authors:  Giorgia Centonze; Dora Natalini; Alessio Piccolantonio; Vincenzo Salemme; Alessandro Morellato; Pietro Arina; Chiara Riganti; Paola Defilippi
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

4.  Nanoparticle-directed and ionically forced polyphosphate coacervation: a versatile and reversible core-shell system for drug delivery.

Authors:  Werner E G Müller; Emad Tolba; Shunfeng Wang; Meik Neufurth; Ingo Lieberwirth; Maximilian Ackermann; Heinz C Schröder; Xiaohong Wang
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

Review 5. 

Authors:  Hironori Tsuchiya; Maki Mizogami
Journal:  Drug Target Insights       Date:  2020-12-22

6.  Effect of Selected Anionic and Cationic Drugs Affecting the Central Nervous System on Electrical Properties of Phosphatidylcholine Liposomes: Experiment and Theory.

Authors:  Joanna Kotyńska; Monika Naumowicz
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

7.  Mutually Exclusive Interactions of Rifabutin with Spatially Distinct Mycobacterial Cell Envelope Membrane Layers Offer Insights into Membrane-Centric Therapy of Infectious Diseases.

Authors:  Anjana P Menon; Wanqian Dong; Tzong-Hsien Lee; Marie-Isabel Aguilar; Mojie Duan; Shobhna Kapoor
Journal:  ACS Bio Med Chem Au       Date:  2022-03-24

8.  Rational Development of Liposomal Hydrogels: A Strategy for Topical Vaginal Antiretroviral Drug Delivery in the Context of HIV Prevention.

Authors:  Maria J Faria; Raul Machado; Artur Ribeiro; Hugo Gonçalves; Maria Elisabete C D Real Oliveira; Teresa Viseu; José das Neves; Marlene Lúcio
Journal:  Pharmaceutics       Date:  2019-09-18       Impact factor: 6.321

Review 9.  Modifications of Plasma Membrane Organization in Cancer Cells for Targeted Therapy.

Authors:  Anna Choromańska; Agnieszka Chwiłkowska; Julita Kulbacka; Dagmara Baczyńska; Nina Rembiałkowska; Anna Szewczyk; Olga Michel; Agnieszka Gajewska-Naryniecka; Dawid Przystupski; Jolanta Saczko
Journal:  Molecules       Date:  2021-03-25       Impact factor: 4.411

10.  An "eat me" combinatory nano-formulation for systemic immunotherapy of solid tumors.

Authors:  Hend Mohamed Abdel-Bar; Adam A Walters; Yau Lim; Nadia Rouatbi; Yue Qin; Fatemeh Gheidari; Shunping Han; Rihab Osman; Julie Tzu-Wen Wang; Khuloud T Al-Jamal
Journal:  Theranostics       Date:  2021-08-11       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.